4//SEC Filing
BROWN MICHAEL S 4
Accession 0001968202-24-000102
CIK 0000872589other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:01 PM ET
Size
10.2 KB
Accession
0001968202-24-000102
Insider Transaction Report
Form 4
BROWN MICHAEL S
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-14$625.60/sh+1,535$960,296→ 2,917 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2024-06-14−1,535→ 0 totalExercise: $625.60Exp: 2032-01-03→ Common Stock (1,535 underlying) - Sale
Common Stock
2024-06-14$1040.00/sh−1,535$1,596,400→ 1,382 total
Holdings
- 6,162(indirect: By Trust)
Common Stock
- 5,000(indirect: by SLAT)
Common Stock
Footnotes (3)
- [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 26, 2024.
- [F2]These shares are held in a trust for the benefit of the reporting person's immediate family members. The reporting person's spouse is trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]On the date of the Issuer's first annual meeting of shareholders following the date of grant, a portion of these stock options equal to the portion of one year that had passed from the date of grant became exercisable, and the remainder became exercisable on the first anniversary of the date of grant.
Documents
Issuer
REGENERON PHARMACEUTICALS, INC.
CIK 0000872589
Entity typeother
Related Parties
1- filerCIK 0001174475
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:01 PM ET
- Size
- 10.2 KB